GNS Partners with NCI on Personalized Treatment of NSCLC | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Healthcare IT firm GNS Healthcare is collaborating with the National Cancer Institute to help determine what treatments may work best for individuals with non-small cell lung cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic factors associated with facial features, a new mutation that makes individuals more prone to Brugada syndrome, and more.

Nutrigenomic companies offer gene-based diet advice, the Wall Street Journal reports.

Researchers have found a new kind of virus — one that starts out broken up into five parts.

Nature News explores the president's "science legacy."